A convergent, stereocontrolled synthesis of C2-symmetrical and pseudosymmetrical sulfur-tethered bis(amino alcohols)

Tetrahedron Letters

Volumn 40, Issue 20, 1999, Pages 3913-3916

  Aguilar, Núria ^a   Moyano, Albert ^a   Pericàs, Miquel A ^a   Riera, Antoni ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Amino alcohols; Asymmetric synthesis; Enzyme inhibitor; Sulfides

Indexed keywords

AMINOALCOHOL; PROTEINASE INHIBITOR;

ARTICLE; DRUG STRUCTURE; ENANTIOMER; REACTION ANALYSIS; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; SYNTHESIS;

EID: 0033553384     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(99)00568-7     Document Type: Article

References (31)

1. 1. For some reviews, see: (a) Norbeck, D. W.; Kempf, D. J. Annu. Rep. Med. Chem. 1991, 26, 141-150.
2. (b) Robins, T.; Plattner, J. J. AIDS 1993, 6, 162-170.
3. (c) Thaisrivongs, S. Annu. Rep. Med. Chem. 1994, 29, 133-144.
4. (d) West, M. L.; Fairlie, D. P. Trends Pharmacol. Sci. 1995, 16, 67-74.
5. (e) De Lucca, G. V.; Erickson-Viitanen, S.; Lam, P. Y. S. Drug Discovery Today 1997, 2, 6-18.
6. 2. See, inter alia: (a) Pollard, R. B. Pharmacotherapy 1994, 14, 21S-29S.
7. (b) Vacca, J. P.; Dorsey, B. D.; Schlief, W. A.; Levin, R. B.; McDaniel, S. L.; Darke, P. L., Zugay, J.; Quintero, J. C.; Blahy, O. M.; Roth, E.; Sardana, V. V.; Schlabach, A. J.; Graham, P. I.; Condra, J. H.; Gotlib, L.; Holloway, M. K.; Lin, J.; Chen, I.-W.; Ostovic, D.; Anderson, P. S.; Emini, E. A.; Huff, J. R. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 4096-4100.
8. (c) Kempf, D. J.; Marsh, K. C.; Denissen, J. F.; McDonald, E.; Vasavanonda, S.; Flentge, C. A.; Green, B. G.; Fino, L.; Park, C. H.; Kong, X.-P.; Wideburg, N. E.; Saldivar, A.; Ruiz, L.; Kati, W. M.; Sham, H. L.; Robins, T.; Stewart, K. D.; Hsu, A.; Plattner, J. J.; Leonard, J. M.; Norbeck, D. W. Proc, Natl. Acad. Sci. U.S.A. 1995, 92, 2484-2488.
9. (d) Kitchen, V. S.; Skinner, C.; Ariyoshi, K.; Lane, E. A.; Duncan, I. B.; Burckhardt, J.; Burger, H. U.; Bragraan, K.; Pinching, A. J.; Weber, J. N. Lancet 1995, 345, 952-955.
10. (e) Lin, J. H. Adv. Drug Delivery Rev. 1997, 27(2,3), 774-778.
11. (f) Vacca, J. P.; Condra, J. H. Drug Discovery Today 1997, 2(7), 261-272.
12. 3. (a) Navia, M. A.; Fitzgerald, P. D. M; McKeever, B. M.; Leu, C.-T.; Heimbach, J. C.; Herber, W. K.; Sigal, I. S.; Darke, P. L.; Springer, J. P. Nature 1989, 337, 615-620.
13. (b) Wlodawer, A.; Miller, M.; Jaskólski, B. K.; Sathyanarayana, B. K.; Baldwin, E.; Weber, I. T.; Selk, L. M.; Clawson, L.; Schneider, J.; Kent, S. B. H. Science 1989, 245, 616-621.
14. 4. Kempf, D. J.; Sowin, T. J.; Doherty, E. M.; Hannick, S. M.; Codacovi, L.; Henry, R. F.; Green, B. E.; Spanton, S. G.; Norbeck, D. W. J. Org. Chem. 1992, 35, 3080-3081.
15. 5. Spaltenstein, A.; Leban, J. J.; Furfine, S. S. Tetrahedron Lett. 1993, 34, 1457-1460.
16. 6. Ettmayer, P.; Hübner, M.; Gstach, H. Tetrahedron Lett. 1994, 35, 3901-3904.
17. 7. Barrish, J. C.; Gordon, E.; Alam, M.; Lin, P.-F.; Bisacchi, G. S.; Chen, P.; Cheng, P. T. W.; Fritz, A. W.; Greytok, J. A.; Hermsmeier, M. A.; Humphreys, W. G.; Lis, K. A.; Marella, M. A.; Merchant, Z.; Mitt, T.; Morrison, R. A.; Obermeier, M. T.; Pluscec, J,; Skoog, M.; Slusarchyk, W. A.; Spergel, S. H.; Stevenson, J. M.; Sun, C.; Sundeen, J. S.; Taunk, P.; Tino, J. A.; Warrack, B. M.; Colonno, R. J.; Zahler, R. J. Med. Chem. 1994, 37, 1758-1768.
18. 8. Lam, P. Y. S.; Jadhav, P. K.; Eyermann, C. J.; Hodge, C. N.; Ru, Y.; Bacheler, L. T.; Meek, J. L.; Otto, M. J.; Rayner, M. M.; Wong, N. Y.; Chang, C.-H.; Weber, P. C.; Jackson, D. A.; Sharpe, T. R.; Erickson-Viitanen, S. Science 1994, 263, 380-384.
19. 9. (a) Winslow, D. L.; Stack, S.; King, R.; Scarnati, H.; Bincsik, A.; Otto, M. J. AIDS Res. Hum. Retroviruses 1995, 11, 107-113.
20. (b) King, R. W.; Garber, S.; Winslow, D. L.; Reid, C.; Bachelor, L. T.; Anton, E.; Otto, M. J. Antiviral Chem. Chemother. 1995, 6, 80-88.
21. 10. These compounds are obtained in high enantiomeric purity by asymmetric epoxidation of (E)-allyl alcohols, followed by the regio- and stereoselective ring opening (by primary amines or by other nitrogen nucleophiles) of the resulting epoxy alcohols: Canas, M.; Poch, M.; Verdaguer, X.; Moyano, A.; Pericàs, M. A.; Riera, A. Tetrahedron Lett. 1991, 32, 6931-6934.
22. 11. (a) Aguilar, N.; Moyano, A.; Pericàs, M. A.; Riera, A. J. Org. Chem. 1998, 63, 3560-3567.
23. (b) Pastó, M.; Moyano, A.; Pericàs, M. A.; Riera, A. Tetrahedron Lett. 1998, 39, 1233-1236.
24. 2-symmetric ligands from 1,4-diamino-2,3-diols, see: Konradi, A. W.; Pedersen, S. F. J. Org. Chem. 1992, 57, 28-32.
25. 13. For the use of anrf-3-amino-1,2-alkanediols in asymmetric catalysis, see: (a) Vidal-Ferran, A.; Moyano, A.; Pericàs, M. A.; Riera, A. J. Org. Chem. 1997, 62, 4970-4982.
26. (b) Vidal-Ferran, A.; Moyano, A.; Pericàs, M. A.; Riera, A. Tetrahedron Lett. 1997, 38, 8773-8776.
27. (c) Vidal-Ferran, A.; Bampos, N.; Moyano, A.; Pericàs, M. A.; Riera, A.; Sanders, J. K. J. Org. Chem. 1998, 63, 6309-6318.
28. 14. Aguilar, N.; Moyano, A.; Pericàs, M. A.; Riera, A. Following paper in this issue.
29. 15. Castejón, P.; Pastó, M.; Moyano, A.; Pericàs, M. A.; Riera, A. Tetrahedron Lett. 1995, 36, 3019-3022.
30. 16. Brittain, J.; Gareau, Y. Tetrahedron Lett. 1993, 34, 3363-3366.
31. 2), 49.5 (CH), 50.1 (CH), 73.6 (2CH), 79.7 (2Cq), 155.8 (Cq), 156.1 (Cq).